BioForest

Found 21,446 articles

• 

  BioSpace Launches 2022 Hotbed Maps to Highlight Thriving Life Sciences Clusters

  1/18/2022

  As BioSpace proudly introduces our 2022 Hotbed Maps, let’s explore the industry’s most thriving territories, research leading employers and search for relevant jobs on BioSpace.

• New Publication Validates SeptiCyte® RAPID as a Triaging Tool for COVID-19 Patients

  2/2/2023

  Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, announced today the publication of a study in Scientific Reports, a journal in the Nature portfolio, validating the use of SeptiCyte® RAPID as a triaging tool for COVID-19 patients requiring hospitalization and potentially ICU care.

• Weill Cornell Medicine and NanoString Collaborate to Create Comprehensive Spatial Atlas of Human Anatomy

  2/2/2023

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced the launch of the Spatial Atlas of Human Anatomy initiative, in collaboration with Weill Cornell Medicine, to create multicellular, single-cell, and sub-cellular maps of 30 non-diseased organs from a healthy and diverse population of adults.

• Alercell Announces Exclusive Distribution Agreement with American Lion Holdings

  2/2/2023

  Alercell, Inc. announced it has entered into an exclusive distribution agreement with American Lion Holdings in which ALH will commercialize Alercell line of surgical operating tables and equipment for hospitals and surgical centers in several states on the East Coast including New York, New Jersey, Connecticut, Kentucky and Florida.

• Know Labs Provides Update on Strategic Partners Engaged in Data Science, Product Engineering and Regulatory Affairs to Accelerate Progress Toward FDA Application

  2/2/2023

  Know Labs, Inc., an emerging developer of non-invasive medical diagnostic technology, shared an update on its strategic partnerships with leading experts in data science, sensor technology, product design and regulatory affairs.

• Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference

  2/2/2023

  Achieve Life Sciences, Inc. today announced it will participate in one-on-one meetings during the 2023 SVB Securities Global Biopharma Conference.

• CTI BioPharma to Participate in Upcoming Investor Conferences in February 2023

  2/2/2023

  CTI BioPharma Corp. (Nasdaq: CTIC) today announced that senior leadership will participate in a Fireside Chat at the following investor conferences in February 2023.

• Sana Biotechnology to Present at the Guggenheim Healthcare Talks 5th Annual Oncology Conference

  2/2/2023

  Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced that it will webcast its presentation at the Guggenheim Healthcare Talks 5th Annual Oncology Conference at 1:00 p.m. ET on Thursday, February 9, 2023.

• Fortive Reports Strong Fourth Quarter and Full Year 2022 Results; Introduces First Quarter and Full Year 2023 Outlook

  2/1/2023

  Fortive Reports Strong Fourth Quarter and Full Year 2022 Results; Introduces First Quarter and Full Year 2023 Outlook.

• Neovasc Announces German Reimbursement Renewal

  2/1/2023

  Neovasc, Inc. announced the German Institute for the Hospital Remuneration System has awarded the Neovasc Reducer™, a CE-Marked medical device for the treatment of refractory angina, NUB Status 1 designation for 2023.

• Athira Pharma Announces Promotion of Kevin Church, Ph.D., to Chief Scientific Officer

  1/31/2023

  Athira Pharma, Inc. today announced the promotion of Kevin Church, Ph.D., to Chief Scientific Officer.

• Gilead Sciences to Present at Upcoming Investor Conferences - Jan 27, 2023

  1/27/2023

  Gilead Sciences, Inc. announced that its executives will be speaking at the following investor conferences: SVB Securities Global Biopharma Conference on Tuesday, February 14 at 11:20 AM Eastern Time Cowen Annual Health Care Conference on Tuesday, March 7 at 11:10 AM Eastern Time Barclays Global Healthcare Conference on Wednesday, March 15 at 10:15 AM Eastern Time The live webcasts can be accessed at the company’s investors page at investors.gilead.com.

• Know Labs Announces Executive Leadership Changes and Confirms 2023 Outlook

  1/27/2023

  Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced changes to its executive leadership team.

• Nautilus Biotechnology Expands to San Diego

  1/26/2023

  Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis platform for quantifying the proteome, announced the opening of its new office space at University Town Center in San Diego, California.

• Know Labs, Inc. Names Ron Erickson Chief Executive Officer; Former CEO Phil Bosua Becomes a Technology Consultant to the Company

  1/26/2023

  Know Labs, Inc. Names Ron Erickson Chief Executive Officer; Former CEO Phil Bosua Becomes a Technology Consultant to the Company.

• Cardiac Dimensions Appoints Angie Swenson as Vice President, Clinical Operations

  1/26/2023

  Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, announced the appointment of Angie Swenson as Vice President of Clinical Operations.

• Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-targeted Allogeneic CAR T Therapy for Patients with B-Cell Malignancies

  1/26/2023

  Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today announced the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application to initiate a first-in-human study of SC291 in patients with various B-cell malignancies.

• Cocrystal Pharma Announces Participation in Virtual Investor Events

  1/26/2023

  Cocrystal Pharma, Inc. (Nasdaq: COCP) announces the participation of James Martin, co-CEO and CFO, in the following virtual investment community events.

• Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

  1/26/2023

  Nautilus Biotechnology, Inc. today announced it will report financial results for the fourth quarter and full year of 2022 before market open on Thursday, February 23, 2023.

• Myosana Therapeutics Raises $5 Million in Seed Funding

  1/25/2023

  Myosana Therapeutics, Inc. today announced the completion of a seed funding round totaling over $5 million led by investor John Ballantyne, Ph.D.